You are here

Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Oslo, , Norway
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Erectile Dysfunction
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males aged 18-65 years who has given written informed consent to participate in the
study and who suffers moderate to severe erectile dysfunction who has a current or
recent successful response to treatment with phosphodiesterase type 5 inhibitors

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Males with a history of significant cardiac disease; unstable angina or recent
myocardial infarction.

- Males suffering from treated or untreated hypo- or hypertension

- Males currently receiving vasoactive medication

- Males taking medications contraindicated, or cautioned with sildenafil or MC4 agonists

NCT00862888
Pfizer
Completed
Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now